# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Vicarious Surgical entered into a securities purchase agreement with a single institutional investor to purchase the Company...
Vicarious Surgical Inc. (NYSE:RBOT, RBOT.WS))) (the "Company"), a next-generation robotics technology company seeking t...
Piper Sandler analyst Adam Maeder maintains Vicarious Surgical (NYSE:RBOT) with a Neutral and lowers the price target from $...
Vicarious Surgical (NYSE:RBOT) reported quarterly losses of $(2.23) per share which beat the analyst consensus estimate of $(2....
Vicarious Surgical (NYSE:RBOT) reported quarterly losses of $(2.58) per share which missed the analyst consensus estimate of $(...